Endovia Health Sciences (EDVA) Gross Profit (2012 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Gross Profit (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.44 Bn | 133.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.65 Bn | 78.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.10 Bn | 59.92 Bn | 1.37 Bn |
| 4 | Moderna | 57.10 Bn | 51.97 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.60 Bn | 44.60 Bn | - |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.48 Bn | 32.17 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.13 Bn | 27.30 Bn | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1,848.00 |
| Dec 31, 2025 | 47,341.00 |
| Sep 30, 2025 | -23,841.00 |
| Jun 30, 2025 | -32,146.00 |
| Mar 31, 2025 | 25,544.00 |
| Dec 31, 2024 | -818,861.00 |
| Sep 30, 2024 | 291,019.00 |
| Jun 30, 2024 | 244,430.00 |
| Mar 31, 2024 | 163,615.00 |
| Dec 31, 2023 | 733,246.00 |
| Sep 30, 2023 | 1.30 Mn |
| Jun 30, 2023 | 1.78 Mn |
| Mar 31, 2023 | 1.76 Mn |
| Dec 31, 2022 | 1.51 Mn |
| Sep 30, 2022 | 1.77 Mn |
| Jun 30, 2022 | 1.35 Mn |
| Mar 31, 2022 | 1.29 Mn |
| Dec 31, 2021 | 1.68 Mn |
| Sep 30, 2021 | 819,849.00 |
| Jun 30, 2021 | 905,053.00 |